Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy (vol 156, 213700, 2024)通过铁死亡为基础的治疗,利用苯基硼酸修饰的PLGA纳米颗粒递送协同药物组合来增强抗癌潜力(卷156,213700,2024)BIOMATERIALS ADVANCESIF62025-07-010PRE
Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer (vol 648, 123570, 2023)INTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22025-01-010PRE
Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclaxINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22024-12-010PRE
Advancing apoptosis induction in triple negative breast cancer: Empowering treatment with tyrosine-stapled mixed micelles of lapatinibJOURNAL OF MOLECULAR LIQUIDSIF5.22024-05-011PRE
Unlocking apoptosis in triple negative breast cancer: Harnessing glutamine trap to amplify the efficacy of lapatinib-loaded mixed micellesBIOMATERIALS ADVANCESIF62024-05-016PRE
Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapyBIOMATERIALS ADVANCESIF62024-01-0110OAAI
Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancerINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22023-12-0121PRE
Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatinINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52023-12-017PRE
Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancerDRUG DELIVERY AND TRANSLATIONAL RESEARCHIF5.52022-12-1727PRE
Self-nanoemulsifying formulation for oral delivery of sildenafil: effect on physicochemical attributes and in vivo pharmacokineticsDRUG DELIVERY AND TRANSLATIONAL RESEARCHIF5.52022-10-128PRE
Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth LiposomesACS BIOMATERIALS SCIENCE & ENGINEERINGIF5.52022-07-2722PRE
Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic ChemotherapyACS BIOMATERIALS SCIENCE & ENGINEERINGIF5.52022-05-0618PRE
Green surfactant-dendrimer aggreplexes: An ingenious way to launch dual attack on arch-enemy cancerCOLLOIDS AND SURFACES B-BIOINTERFACESIF5.62021-08-014PREAI
Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug DeliveryACS BIOMATERIALS SCIENCE & ENGINEERINGIF5.52021-02-1512PREAI
Succinylated β-Lactoglobuline-Functionalized Multiwalled Carbon Nanotubes with Improved Colloidal Stability and BiocompatibilityACS BIOMATERIALS SCIENCE & ENGINEERINGIF5.52019-05-2421PREAI
Lipid-polymer hybrid nanocarriers for delivering cancer therapeuticsJOURNAL OF CONTROLLED RELEASEIF11.52018-02-01124PREAI